187 related articles for article (PubMed ID: 37209450)
21. 1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Xu Z; Zhao SJ; Liu Y
Eur J Med Chem; 2019 Dec; 183():111700. PubMed ID: 31546197
[TBL] [Abstract][Full Text] [Related]
22. Cinnamic acid hybrids as anticancer agents: A mini-review.
Feng LS; Cheng JB; Su WQ; Li HZ; Xiao T; Chen DA; Zhang ZL
Arch Pharm (Weinheim); 2022 Jul; 355(7):e2200052. PubMed ID: 35419808
[TBL] [Abstract][Full Text] [Related]
23. Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids.
Dai H; Huang M; Qian J; Liu J; Meng C; Li Y; Ming G; Zhang T; Wang S; Shi Y; Yao Y; Ge S; Zhang Y; Ling Y
Eur J Med Chem; 2019 Mar; 166():470-479. PubMed ID: 30739827
[TBL] [Abstract][Full Text] [Related]
24. Anticancer potential of cardiac glycosides and steroid-azole hybrids.
Hou Y; Shang C; Meng T; Lou W
Steroids; 2021 Jul; 171():108852. PubMed ID: 33887267
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic Outlook of Pyrazole Analogs: A Mini Review.
Ganguly S; Jacob SK
Mini Rev Med Chem; 2017; 17(11):959-983. PubMed ID: 26586126
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of New Pyrazole Hybrids as Potential Anticancer Agents with Xanthine Oxidase Inhibitory Activity.
Alsayari A; Asiri YI; Bin Muhsinah A; Hassan MZ
Anticancer Agents Med Chem; 2022; 22(12):2303-2309. PubMed ID: 35016597
[TBL] [Abstract][Full Text] [Related]
27. Triarylpyrazole Derivatives as Potent Cytotoxic Agents; Synthesis and Bioactivity Evaluation "Pyrazole Derivatives as Anticancer Agent".
Sameem B; Moghadam ES; Darabi M; Shahsavari Z; Amini M
Drug Res (Stuttg); 2021 Sep; 71(7):388-394. PubMed ID: 34010979
[TBL] [Abstract][Full Text] [Related]
28. Pyrazole-based analogs as potential antibacterial agents against methicillin-resistance staphylococcus aureus (MRSA) and its SAR elucidation.
Verma R; Verma SK; Rakesh KP; Girish YR; Ashrafizadeh M; Sharath Kumar KS; Rangappa KS
Eur J Med Chem; 2021 Feb; 212():113134. PubMed ID: 33395624
[TBL] [Abstract][Full Text] [Related]
29. 1,3,5-Triazine-azole Hybrids and their Anticancer Activity.
Guo H; Diao QP
Curr Top Med Chem; 2020; 20(16):1481-1492. PubMed ID: 32156236
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011-2020): Current Status and Future Prospects.
El-Gamal MI; Zaraei SO; Madkour MM; Anbar HS
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011562
[TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of pyrazole-pyrazoline hybrids as cancer-associated selective COX-2 inhibitors.
Akhtar W; Marella A; Alam MM; Khan MF; Akhtar M; Anwer T; Khan F; Naematullah M; Azam F; Rizvi MA; Shaquiquzzaman M
Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000116. PubMed ID: 33015829
[TBL] [Abstract][Full Text] [Related]
32. A Molecular Insight into Pyrazole Congeners as Antimicrobial, Anticancer, and Antimalarial Agents.
Karati D; Mahadik KR; Trivedi P; Kumar D
Med Chem; 2022; 18(10):1044-1059. PubMed ID: 35240964
[TBL] [Abstract][Full Text] [Related]
33. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
Shi JB; Tang WJ; Qi XB; Li R; Liu XH
Eur J Med Chem; 2015 Jan; 90():889-96. PubMed ID: 25554922
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of Chromone-Related Pyrazole Compounds.
Santos CMM; Silva VLM; Silva AMS
Molecules; 2017 Oct; 22(10):. PubMed ID: 28981465
[TBL] [Abstract][Full Text] [Related]
35. Hydroxamic acid hybrids as the potential anticancer agents: An Overview.
Liu W; Liang Y; Si X
Eur J Med Chem; 2020 Nov; 205():112679. PubMed ID: 32791404
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of thiazolidinone-pyrazole conjugates as anticancer and antimicrobial agents.
Bhat M; Poojary B; Kalal BS; Gurubasavaraja Swamy PM; Kabilan S; Kumar V; Shruthi N; Alias Anand SA; Pai VR
Future Med Chem; 2018 May; 10(9):1017-1036. PubMed ID: 29708431
[TBL] [Abstract][Full Text] [Related]
37. Inherent efficacies of pyrazole-based derivatives for cancer therapy: the interface between experiment and
Dube ZF; Soremekun OS; Ntombela T; Alahmdi MI; Abo-Dya NE; Sidhom PA; Shawky AM; Shibl MF; Ibrahim MA; Soliman ME
Future Med Chem; 2023 Sep; 15(18):1719-1738. PubMed ID: 37772542
[TBL] [Abstract][Full Text] [Related]
38. Tetrazole hybrids with potential anticancer activity.
Zhang J; Wang S; Ba Y; Xu Z
Eur J Med Chem; 2019 Sep; 178():341-351. PubMed ID: 31200236
[TBL] [Abstract][Full Text] [Related]
39. Artemisinin-derived hybrids and their anticancer activity.
Gao F; Sun Z; Kong F; Xiao J
Eur J Med Chem; 2020 Feb; 188():112044. PubMed ID: 31945642
[TBL] [Abstract][Full Text] [Related]
40. Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020).
Xiao J; Gao M; Sun Z; Diao Q; Wang P; Gao F
Eur J Med Chem; 2020 Dec; 208():112830. PubMed ID: 32992133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
